1. Home
  2. CASI vs ARKR Comparison

CASI vs ARKR Comparison

Compare CASI & ARKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • ARKR
  • Stock Information
  • Founded
  • CASI 1991
  • ARKR 1983
  • Country
  • CASI China
  • ARKR United States
  • Employees
  • CASI N/A
  • ARKR N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • ARKR Restaurants
  • Sector
  • CASI Health Care
  • ARKR Consumer Discretionary
  • Exchange
  • CASI Nasdaq
  • ARKR Nasdaq
  • Market Cap
  • CASI 58.8M
  • ARKR 47.4M
  • IPO Year
  • CASI 1996
  • ARKR N/A
  • Fundamental
  • Price
  • CASI $2.36
  • ARKR $13.11
  • Analyst Decision
  • CASI Strong Buy
  • ARKR
  • Analyst Count
  • CASI 1
  • ARKR 0
  • Target Price
  • CASI $6.00
  • ARKR N/A
  • AVG Volume (30 Days)
  • CASI 30.6K
  • ARKR 5.8K
  • Earning Date
  • CASI 11-15-2024
  • ARKR 02-10-2025
  • Dividend Yield
  • CASI N/A
  • ARKR 2.72%
  • EPS Growth
  • CASI N/A
  • ARKR N/A
  • EPS
  • CASI N/A
  • ARKR N/A
  • Revenue
  • CASI $22,055,000.00
  • ARKR $183,545,000.00
  • Revenue This Year
  • CASI N/A
  • ARKR N/A
  • Revenue Next Year
  • CASI $134.79
  • ARKR N/A
  • P/E Ratio
  • CASI N/A
  • ARKR N/A
  • Revenue Growth
  • CASI N/A
  • ARKR N/A
  • 52 Week Low
  • CASI $2.05
  • ARKR $9.75
  • 52 Week High
  • CASI $7.67
  • ARKR $17.76
  • Technical
  • Relative Strength Index (RSI)
  • CASI 33.52
  • ARKR 48.01
  • Support Level
  • CASI $2.27
  • ARKR $12.99
  • Resistance Level
  • CASI $2.73
  • ARKR $13.77
  • Average True Range (ATR)
  • CASI 0.24
  • ARKR 0.55
  • MACD
  • CASI 0.02
  • ARKR -0.20
  • Stochastic Oscillator
  • CASI 12.70
  • ARKR 2.97

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About ARKR Ark Restaurants Corp.

Ark Restaurants Corp owns and operates around 17 restaurants and bars, 16 fast food concepts, and catering operations in the USA. The Las Vegas operations include New York Hotel & Casino Resort, hotel room service operations, banquet facilities, employee dining room, food court concepts, and a restaurant within the Planet Hollywood Resort and Casino. It operates a restaurant and a bar in the Resorts Atlantic City Hotel and Casino and a restaurant in the Tropicana Hotel and Casino. The Florida operations include The Rustic Inn in Dania Beach, Shuckers in Jensen Beach, JB's on the Beach in Deerfield Beach, The Blue Moon Fish Company in Fort Lauderdale, and fast food facilities in Tampa and Hollywood. In Alabama, it operates Original Oyster Houses in Gulf Shores and Spanish Fort.

Share on Social Networks: